Ensuring strict control measures are essential to meet regulatory guidelines related to the potential presence of mutagenic impurities in medicines, specifically nitrosamines.
Waters provides accessible LC/MS and MS/MS solutions enabling the development of sensitive, accurate and robust analytical methodologies for the detection and quantification of all types of nitrosamines and their precursors.
From drug development through to manufacturing QC, join forces with Waters as you effectively navigate regulatory guidelines and support both patient safety and the ongoing supply of critical medicines.